PD-L1 IHC Immunotherapy Test | Lahalak Platform
The key to smart cancer treatment; determines tumor response to modern immunotherapy, helping make precise, personalized treatment decisions that increase the chances of recovery.
Scientific name: Immunohistochemistry (IHC) for PD-L1
Immunohistochemical assay (IHC) measures the expression level of PD-L1 (Programmed Death-Ligand 1) protein on the surface of cancer cells or immune cells within a tumor. PD-L1 protein binds to the PD-1 receptor on T cells, suppressing the immune response against the tumor. This assay is used as a predictive marker for selecting patients who are can...
Service type
Histopathology laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Accurate analysis to diagnose PD-L1 expression in tumor tissue samples.
- Consult with a pathologist and an oncologist to interpret the results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- The analysis does not require the patient to fast, as it relies on a previously preserved tumor tissue sample (biopsy).
- It is necessary to provide a properly prepared tissue block (paraffin block) or microscopic slides from the diagnostic tumor biopsy.
- The diagnosis of the histological tumor must be known and attached to the sample.
Medical services you might also like
